Bibliometric analysis of the highly cited publications in COVID-19 vaccine
The coronavirus disease 2019 (COVID-19) pandemic has had widespread effects across the globe and continues to affect global public health. This study aims to select and feature highly cited publications on the COVID-19 vaccine. The Web of Science core database was used to extract relevant articles p...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-08-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023057481 |
| _version_ | 1797733004746948608 |
|---|---|
| author | Li Yan Lihua Liu |
| author_facet | Li Yan Lihua Liu |
| author_sort | Li Yan |
| collection | DOAJ |
| description | The coronavirus disease 2019 (COVID-19) pandemic has had widespread effects across the globe and continues to affect global public health. This study aims to select and feature highly cited publications on the COVID-19 vaccine. The Web of Science core database was used to extract relevant articles published in recent years. Progress of vaccine studies made in recent two years has mainly focused on the development of different vaccines and the evaluation of their safety and efficacy for population immunity. Clinical trials mainly focusing on the safety and efficacy of diverse vaccines have flourished. Lipid nanoparticle-formulated, nucleoside-modified RNA vaccine and recombinant adenovirus type-5 (26) vectored SARS-CoV-2 vaccines are most commonly studied. Vaccine application-associated challenges mainly include antibody resistance of new variants and unusual severe complications. The correlation between booster immunizations and reinfection is still in the explored state. Currently, antibody resistance of emerging variants is the main vaccine application-associated challenge and the primary reason for vaccine hesitancy. Effective strategies for reinfection prevention are also urgently needed. |
| first_indexed | 2024-03-12T12:22:41Z |
| format | Article |
| id | doaj.art-87bcf554bd58406ab0067871da621e47 |
| institution | Directory Open Access Journal |
| issn | 2405-8440 |
| language | English |
| last_indexed | 2024-03-12T12:22:41Z |
| publishDate | 2023-08-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Heliyon |
| spelling | doaj.art-87bcf554bd58406ab0067871da621e472023-08-30T05:51:41ZengElsevierHeliyon2405-84402023-08-0198e18540Bibliometric analysis of the highly cited publications in COVID-19 vaccineLi Yan0Lihua Liu1Cadet Company One, Graduate School of Chinese PLA General Hospital, Beijing, 100853, ChinaInstitution of Hospital Management, Department of Medical Innovation and Research, Chinese PLA General Hospital, Beijing 100853, China; Corresponding author.The coronavirus disease 2019 (COVID-19) pandemic has had widespread effects across the globe and continues to affect global public health. This study aims to select and feature highly cited publications on the COVID-19 vaccine. The Web of Science core database was used to extract relevant articles published in recent years. Progress of vaccine studies made in recent two years has mainly focused on the development of different vaccines and the evaluation of their safety and efficacy for population immunity. Clinical trials mainly focusing on the safety and efficacy of diverse vaccines have flourished. Lipid nanoparticle-formulated, nucleoside-modified RNA vaccine and recombinant adenovirus type-5 (26) vectored SARS-CoV-2 vaccines are most commonly studied. Vaccine application-associated challenges mainly include antibody resistance of new variants and unusual severe complications. The correlation between booster immunizations and reinfection is still in the explored state. Currently, antibody resistance of emerging variants is the main vaccine application-associated challenge and the primary reason for vaccine hesitancy. Effective strategies for reinfection prevention are also urgently needed.http://www.sciencedirect.com/science/article/pii/S2405844023057481SARS-CoV-2Vaccine designAntibody resistanceClinical trialsBibliometric analysisPublic health |
| spellingShingle | Li Yan Lihua Liu Bibliometric analysis of the highly cited publications in COVID-19 vaccine Heliyon SARS-CoV-2 Vaccine design Antibody resistance Clinical trials Bibliometric analysis Public health |
| title | Bibliometric analysis of the highly cited publications in COVID-19 vaccine |
| title_full | Bibliometric analysis of the highly cited publications in COVID-19 vaccine |
| title_fullStr | Bibliometric analysis of the highly cited publications in COVID-19 vaccine |
| title_full_unstemmed | Bibliometric analysis of the highly cited publications in COVID-19 vaccine |
| title_short | Bibliometric analysis of the highly cited publications in COVID-19 vaccine |
| title_sort | bibliometric analysis of the highly cited publications in covid 19 vaccine |
| topic | SARS-CoV-2 Vaccine design Antibody resistance Clinical trials Bibliometric analysis Public health |
| url | http://www.sciencedirect.com/science/article/pii/S2405844023057481 |
| work_keys_str_mv | AT liyan bibliometricanalysisofthehighlycitedpublicationsincovid19vaccine AT lihualiu bibliometricanalysisofthehighlycitedpublicationsincovid19vaccine |